Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6087]

IND clearance from FDA for ISM5939, an oral ENPP1 inhibitor treating solid tumours

IND clearance from FDA for ISM5939, an oral ENPP1 inhibitor treating solid tumours

Polyphyllin II suppresses cell migration, invasion, and metastasis by inducing cytoskeletal rearrangement through the ROCK1/LIMK/CFL1 pathway in bladder cancer cells

Polyphyllin II suppresses cell migration, invasion, and metastasis by inducing cytoskeletal rearrangement through...

FDA approves updated drug labeling for fludarabine phosphate under Project Renewal

FDA approves updated drug labeling for fludarabine phosphate under Project Renewal

First molecule identified that promotes gut healing while inhibiting tumour progression

First molecule identified that promotes gut healing while inhibiting tumour progression

Probiotic delivers anticancer drug to the gut

Probiotic delivers anticancer drug to the gut

New study unveils key strategies against drug-resistant prostate cancer

New study unveils key strategies against drug-resistant prostate cancer

Amivantamab in combination with lazertinib for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer

Amivantamab in combination with lazertinib for the first-line treatment of patients with EGFR-mutated advanced non...

$FDA approves revumenib for relapsed or refractory acute leukaemia with a KMT2A translocation$

FDA approves revumenib for relapsed or refractory acute leukaemia with a KMT2A translocation

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

Novel CAR T-cell therapy demonstrates efficacy and safety in preclinical models of HER2-positive solid tumors

Study reveals significant global disparities in cancer care across different countries

Study reveals significant global disparities in cancer care across different countries

More from ecancer